Skip to content

Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP

Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03176017
Enrollment
40
Registered
2017-06-05
Start date
2020-10-01
Completion date
2021-10-01
Last updated
2020-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ejaculatory Dysfunction, Prostate Hyperplasia, Transurethral Incision Of The Prostate

Keywords

Transurethral Incision Of The Prostate, Prostate, Ejaculatory Sparing

Brief summary

In this study, Investigators planned to compare ejaculatory sparing and non-ejaculatory sparing (conventional) TUIP using both subjective and objective assessment tools for the degree of deobstruction. Furthermore, the impact of both techniques on ejaculation and its secondary effect on orgasm perception and different domains of sexual function will be thoroughly assessed.

Interventions

PROCEDUREEjaculatory sparing TUIP

The bladder neck will be incised and vaporized at the 5 or 7-o'clock position. The incision will start near the ureteral orifice and carry downward to about 0.5-1.0 cm proximal to the verumontanum

PROCEDUREConventional TUIP

the bladder neck will be incised by Collins knife at the 5 or 7-o'clock position till the verumontanum.

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* American society of anesthesiologists (ASA) score ≤3. * TRUS estimated prostate weight ≤ 35 grams. * Sexually interested and having continuous relationship with the same partner (interested). * Bladder outlet obstruction index (BOOI ) ≥ 20 as per pressure flow study

Exclusion criteria

* Preoperative sexual or ejaculatory disturbances or pelvic pain syndrome * Neurological disorders that can affect potency and ejaculation e.g. long standing uncontrolled diabetes mellitus (DM) type 2 (\> 10 years), DM type 1, cerebral stroke, Parkinsonism * Urodynamic changes consistent with urethropathy or detrusor hypocontractility * Previous pelvic surgeries or radiotherapy

Design outcomes

Primary

MeasureTime frameDescription
impact on ejaculatory function and subsequently the impact of reported ejaculatory changes on orgasm perception1 yearEjaculatory domain of Male sexual health questionnaire (Ej-MSHQ)

Secondary

MeasureTime frameDescription
Erectile function domains (erectile function, orgasm, desire, intercourse satisfaction and overall satisfaction)1 yearInternational index of erectile function-15 (IIEF-15) questionnaire
Patient reported functional urinary outcomes1 yearInternational prostate symptom score (IPSS) questionnaire
maximum flow rate (Q.max)1 yearmilliliters per second.

Countries

Egypt

Contacts

Primary ContactAbdelwahab R. Hashem, Msc
abdelwahab_hashem@yahoo.com01069678979
Backup ContactAhmed Alhussein, MBBCH
ahmedalhussein20@gmail.com00201009074121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026